Maisam Tobeh
Research Subjects
Maisam Tobeh has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Abdalhakim Shubietah
Department of Medicine Advocate Illinois Masonic Medical Center Chicago Illinois USA
1 shared publication - Abubakar Nazir
Department of Medicine King Edward Medical University Lahore Pakistan
1 shared publication - Ahmed Emara
Faculty of Medicine, Al-Azhar University, Cairo, Egypt
1 shared publication - Ameer Awashra
Department of Medicine, An Najah National University, Nablus, Palestine
1 shared publication - Anwar Zahran
Department of Medicine, Faculty of Medicine and Health Sciences An‐Najah National University Nablus Palestine
1 shared publication Fathi Milhem
Department of Medicine An‐Najah National University Nablus Palestine
1 shared publication
Latest Publications
- 14 September 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (6) , 3136-3142
Increasing Acute Coronary Syndrome Mortality in Cirrhosis After a Period of Decline: A National Analysis of Temporal and Demographic Disparities
Background: How acute coronary syndrome (ACS) mortality has evolved among people with cirrhosis at the national level is unclear, and the clinical implications for cardio‐hepatic care are underdefined. Methods: Using CDC WONDER mortality files (1999–2020), we identified deaths with ACS as the underlying cause and cirrhosis listed among multiple causes, computed age‐adjusted mortality rates (AAMRs; per 100,000), and modeled trends with Joinpoint regression. Subgroups included sex, race/ethnicity, urbanization, and place of death. Results: We identified 10,319 cirrhosis‐associated ACS deaths; the overall AAMR was 0.22. Rates were higher in men than women (0.33 vs. 0.12) and higher in Hispanic than non‐Hispanic individuals (0.31 vs. 0.20). American Indian/Alaska Native had the highest AAMR (0.34). Rural noncore counties had the highest AAMR (0.28). Joinpoint detected a national inflection in 2014: AAMR declined from 1999 to 2014 (APC − 3.49%) and increased thereafter (APC + 5.38%), with an overall AAPC of −1.03%. Conclusions: After years of decline, cirrhosis‐associated ACS mortality has risen since 2014, with persistent disparities by sex, race/ethnicity, and rurality. These data support integrated cardio‐hepatic pathways, targeted outreach to rural and historically underserved groups, and system‐level quality improvement focused on time‐sensitive ACS care in cirrhosis.
- 14 September 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (6) , 3136-3142
Increasing Acute Coronary Syndrome Mortality in Cirrhosis After a Period of Decline: A National Analysis of Temporal and Demographic Disparities
Background: How acute coronary syndrome (ACS) mortality has evolved among people with cirrhosis at the national level is unclear, and the clinical implications for cardio‐hepatic care are underdefined. Methods: Using CDC WONDER mortality files (1999–2020), we identified deaths with ACS as the underlying cause and cirrhosis listed among multiple causes, computed age‐adjusted mortality rates (AAMRs; per 100,000), and modeled trends with Joinpoint regression. Subgroups included sex, race/ethnicity, urbanization, and place of death. Results: We identified 10,319 cirrhosis‐associated ACS deaths; the overall AAMR was 0.22. Rates were higher in men than women (0.33 vs. 0.12) and higher in Hispanic than non‐Hispanic individuals (0.31 vs. 0.20). American Indian/Alaska Native had the highest AAMR (0.34). Rural noncore counties had the highest AAMR (0.28). Joinpoint detected a national inflection in 2014: AAMR declined from 1999 to 2014 (APC − 3.49%) and increased thereafter (APC + 5.38%), with an overall AAPC of −1.03%. Conclusions: After years of decline, cirrhosis‐associated ACS mortality has risen since 2014, with persistent disparities by sex, race/ethnicity, and rurality. These data support integrated cardio‐hepatic pathways, targeted outreach to rural and historically underserved groups, and system‐level quality improvement focused on time‐sensitive ACS care in cirrhosis.